Dr. Michael Roberts is Deputy Chief Scientist of the International Space Station (ISS) U.S. National Laboratory where he works to solicit, select, develop and enable flight projects for the orbiting microgravity laboratory. During his time at the ISS National Lab, Dr. Roberts has lead a team that has partnered with multiple Fortune 500 pharmaceutical companies seeking to leverage the space station to enhance therapeutics and disease understanding, along with innovative startup biotech companies, and funding entities like the National Institutes of Health and the National Science Foundation. Prior to joining the ISS National Lab, Michael worked as a NASA Advanced Life Support program microbial ecologist, molecular biologist and group lead at the Kennedy Space Center. Michael has been PI and Co-I on NASA flight experiments on Shuttle and ISS focused on bacterial recombination, plant-microbe interactions, and forward osmosis membrane technology for water recovery in microgravity. He has a B.A. from Maryville College, a Ph.D. in microbiology from Wesleyan University, and was a post-doctoral researcher in the Center for Microbial Ecology at Michigan State University and the RIKEN Institute in Wako-shi, Japan.